mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.04 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.061 |
0.05 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.05 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.05 |
mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
-0.068 |
0.05 |
mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
-0.064 |
0.05 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.05 |
mRNA |
XMD15-27 |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.05 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
0.05 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.06 |